CHINESE JOURNAL OF DRUG EVALUATION >

2026 , Vol. 43 >Issue 2: 138 - 138-142

DOI: https://doi.org/magtech-2025-09-22-00001

Impact of Xuesaitong Injection as Adjuvant Therapy on Cerebral Hemodynamics and Levels of Nerve-Related Factors in Patients with AIS-LVO

Expand
  • Baofeng Branch， Second People′s Hospital of Pingdingshan City， Henan Pingdingshan 467400， China

Received date: 2025-09-22

  Revised date: 2025-10-16

  Accepted date: 2026-05-19

  Online published: 2026-05-19

Fold

Abstract

Objective： To explore the efficacy of xuesaitong injection as adjuvant therapy for patients with acute ischemic stroke due to large vessel occlusion (AIS-LVO)， as well as its impact on cerebral hemodynamics and neurotrophic factor levels. Methods： The clinical data of 100 AIS-LVO patients in our hospital (from November 2023 to October 2024) were retrospectively collected and divided into two groups according to different treatment schemes. 48 patients in the control group were treated with edaravone and dexborneol injection， and 52 patients in the study group were treated with xuesaitong injection on the basis of the control group. The efficacy and incidence of adverse reactions were compared between the two groups， as well as the levels of cerebral hemodynamics indicators [mean blood flow rate (Vm)， peripheral resistance (Rv)， mean blood flow (Qm)， dynamic resistance (DR)]， modified Rankin scale (mRS) score， National Institutes of Health Stroke Scale (NIHSS) score， nerve-related factors [glial fibrillary acidic protein (GFAP)， S100 calcium-binding protein β(S100β)， neurotrophic factor 3 (NT-3)， brain-derived neurotrophic factor (BDNF)]， oxidative stress response [malondialdehyde (MDA)， glutathione peroxidase (GSH-Px) ] were compared between the two groups before the treatment and 14 d after the treatment. Results： The total effective rate of the study group was 84.62% (44/52)， which was higher than that of the control group [66.67%(32/48)] (P<0.05). After 14 d of treatment， the levels of Vm， Qm， serum NT-3， BDNF and GSH-Px of patients in the study group were higher than those in the control group， and the Rv， DR， mRS， NIHSS scores and serum GFAP， S100β and MDA levels were lower than those in the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion： In the treatment of AIS-LVO patients， on the basis of edaravone and dexborneol injection treatment， the combined application of xuesaitong injection can effectively improve the curative effect， regulate the levels of nerve-related factors， improve the levels of cerebral hemodynamics and nerve function， alleviate the oxidative stress reaction of the body， and have high safety.

Key words： ; font-size:medium; ">Xuesaitong injection； AIS-LVO； Nerve-related factors； Adverse reactions； Cerebral hemodynamics

Cite this article

WANG Fengge, YANG Bingwei . Impact of Xuesaitong Injection as Adjuvant Therapy on Cerebral Hemodynamics and Levels of Nerve-Related Factors in Patients with AIS-LVO[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026 , 43(2) : 138 -138-142 . DOI: magtech-2025-09-22-00001

References

 [1] 陈浪，李瑞，殷亚美，等. 血浆Elabela水平预测大血管闭塞型急性缺血性脑卒中患者血管内机械取栓术后近期预后的临床研究[J]. 中华神经医学杂志，2023，22(12)：1242-1247.
     [2] 张谷裕，郭树彬，梅雪，等. 高密度脂蛋白在预测大血管闭塞型急性缺血性脑卒中发病风险中的作用[J]. 中国急救医学，2024，44(12)：1036-1041.
     [3] 郝瑜，刘超，曹银光，等. 大血管闭塞型急性缺血性脑卒中患者血清PTX3水平与机械取栓首次通过效应及预后的相关性研究[J]. 现代检验医学杂志，2024，39(4)：110-115.
     [4] 向浩，徐萌萌，尹琳. 血管内治疗急性大血管闭塞性缺血性脑卒中预后相关因素分析[J]. 中华老年心脑血管病杂志，2024，26(3)：313-316.
     [5] 高宗恩，郎野，刘文虎. 急性缺血性脑卒中血管开通治疗时间窗的演变及发展趋势[J]. 中华神经医学杂志，2024，23(7)：741-747.
     [6] 黄惠红，冯强，严佳，等. 脑心同治针法联合依达拉奉右莰醇注射用浓溶液治疗缺血性脑卒中的临床研究[J]. 四川中医，2024，42(4)：206-210.
     [7] 李文娟，柴丽红. 血塞通注射液对老年急性脑梗死患者神经细胞因子的影响[J]. 中华保健医学杂志，2025，27(2)：345-347.
     [8] 中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志，2018，51(9)：666-682.
     [9] 杨洋，李春娇. 大血管闭塞性急性缺血性脑卒中患者治疗后梗死核心体积动态变化及其相关因素分析[J]. 中华老年心脑血管病杂志，2024，26(7)：802-805.
     [10] 陈英道，李国辉，张岐平，等. 前循环大血管闭塞型急性缺血性脑卒中患者机械取栓术后预后不良的影响因素分析及其风险预测列线图模型构建[J]. 实用心脑肺血管病杂志，2025，33(5)：52-58.
     [11] 蒋雅，孙萍，伍国锋，等. 大血管闭塞性急性缺血性脑卒中病人血管介入机械取栓治疗预后的影响因素[J]. 中西医结合心脑血管病杂志，2024，22(19)：3601-3607.
     [12] 李中辰，郝继恒，张文玉，等. 机械取栓联合脐带血单个核细胞移植改善急性颅内大血管闭塞性缺血性脑卒中患者预后的研究[J]. 中风与神经疾病杂志，2025，42(1)：47-51.
     [13] 幸文利，谭关平，段佳. 前循环大血管闭塞急性缺血性脑卒中机械取栓后脑水肿严重程度及预后影响因素[J]. 重庆医学，2024，53(4)：582-586.
     [14] 郑俊飞，闫学磊，曹学民，等. 急性大血管闭塞性缺血性脑卒中患者行机械取栓治疗后的预后影响因素的研究进展[J]. 广西医学，2023，45(14)：1755-1759.
     [15] Chen L， Liu F， Tian X， et al. Impact of cerebral microbleeds on cognitive functions and its risk factors in acute cerebral infarction patients[J]. Neurol Res， 2023， 45(6)：564-571.
     [16] Xu Z， Weng X， Cao L， et al. Correlation analysis of serum 3-NT， NPASDP-4， and S100β protein levels with cognitive function in patients diagnosed with cerebral infarction[J]. Altern Ther Health Med， 2024， 30(4)：54-59.
     [17] Kongsui R， Thongrong S， Jittiwat J. In vivo neuroprotective effects of alpinetin against experimental ischemic stroke damage through antioxidant and anti-inflammatory mechanisms[J]. Int J Mol Sci， 2025， 26(11)：5093.
     [18] Zhong FF， Wei B， Bao GX， et al. FABP3 induces mitochondrial autophagy to promote neuronal cell apoptosis in brain ischemia-reperfusion injury[J]. Neurotox Res， 2024， 42(4)：35.
Options
Outlines

/

〈 〉

[an error occurred while processing this directive]